maria sepulveda

[Neuroimmunology Clinic Barcelona @neuroimmuclinic]

🚀 We are sharing our last work! Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study
https://t.co/JwjqJ1QIXj

[Giovanni Di Liberto @DiLibertoMD]

Severe anti-NMDAR encephalitis doesn’t always mean irreversible damage. In this international study led by Josep Dalmau & Mar Guasp), ~2/3 of patients in prolonged vegetative state (≥9 months) improved—1/3 fully.
Late recovery is real.
#Neuroimmunology https://t.co/s9RcepegeR

[Neuroimmunology Clinic Barcelona @neuroimmuclinic]

El Dr Dalmau nos da su visión sobre las encefalitis autoinmunes como entidades nosológicas individuales y su impacto interdisciplinario.

[Neuroimmunology Clinic Barcelona @neuroimmuclinic]

Talking about IgLON5...

[Dr. Lidia Sabater @LidiaSabater1]

Let me explain IGNITION consortium's logo: Two hemispheres of the #brain 🧠.
One 🚀 IGNITION rocket-antibodies against @iglon5
The other half, containing neurodegeneration. Let's solve this mistery together🔎. Apply for the #PhDposition fully funded by EU #MSCA-DN actions

[The MOG Project @TheMOGProject]

A historic moment for the MOGAD community!

Positive Phase III results from the METEOROID clinical trial mark the first successful MOGAD treatment study—made possible by the participants and their families.

As the pre-eminent global nonprofit for #MOGAD, The MOG Project calls this a “historic day” and applauds “Hoffmann-LaRoche/Genentech’s landmark achievement and their investment in finding new, safe, and effective treatments for MOGAD.”

Learn more: https://t.co/MFyIiJZVpr

[Georgina Arrambide @GeoArrambide]

We had a fruitful @ECTRIMS Winter School about NMOSD and MOGAD highlighting worldwide disparities on Ab testing and treatment access, current knowledge and the way forward. @marignierro @SaraMariottoMD @MSGazquez @MarTintore @cobo_calvo @RosaCortese5 @EoinFlanagan14 and many more

[Dr. Lidia Sabater @LidiaSabater1]

I'm looking for candidates with master degree in neuroscience interested in applying for a PFIS grant (2026 call, predoctoral position). I have a FIS project funded about demyelinating diseases👩‍⚕️. Good degree scores🤷‍♀️ mandatory😎

[Neuroimmunology Clinic Barcelona @neuroimmuclinic]

‼️We are sharing our last paper review:

[Neuroimmunology Clinic Barcelona @neuroimmuclinic]

🔊 #SaveTheDate

[Neuroimmunology Clinic Barcelona @neuroimmuclinic]

🔊 Mañana tendrá lugar el II Encuentro Nacional entre pacientes con #NMOSD o #MOGAD, médicos y otros profesionales especializados en su atención.

👫👭👬 Un espacio para aprender, compartir y avanzar juntos.

[Neuroimmunology Clinic Barcelona @neuroimmuclinic]

✨ Barcelona, the world’s hub for multiple sclerosis for some days.
We are proud that our city is hosting #ECTRIMS2025, the largest international meeting in MS.
An exceptional opportunity to share knowledge, highlight innovation, and strengthen our commitment to patients.

[Neurology Journal @GreenJournal]

(2) patients who initially present with overlapping features of MOGAD and MS but predominantly follow an MS-like course. Read the article: https://t.co/bKpw1iEZQa

(2/2)

[Neurology Journal @GreenJournal]

This study demonstrates 4% of children with MOG-IgG meet criteria for MS at some point during disease course. It also identifies 2 distinct clinical profiles: (1) patients who exhibit typical MS features & follow a disease trajectory indistinguishable from prototypical MS (1/2)

[Cemcat @cemcat_em]

⏳ 2 hours to go!
Casos clínicos en EM Pediátrica returns with a focus on MOGAD treatment across ages.

How does management differ in children vs. adults?
📅 Today | 15:00–16:00h
🎙️ With Prof. Yael Hacohen & Dra. Maria Sepúlveda
🎤 Moderated by Dra. Georgina Arrambide
🔗 https://t.co/3TKLqvx7cO

#MOGAD #Neuroinmunología #EsclerosisMúltiple

[Neuroimmunology Clinic Barcelona @neuroimmuclinic]

Dr Eugenia Martínez in the controversy session about testing for the diagnosis of autoimmune encephalitis at #ean25 @EANeurology

[Neuroimmunology Clinic Barcelona @neuroimmuclinic]

💡 We have developed a new mouse model for anti-NMDAR encephalitis will indeed deepen the understanding of the disease's pathophysiology and potentially accelerate treatment discovery.

[ImaginEM @EmImagin]

Celebraremos la XV reunión anual de pacientes de EM con la Unidad de Neuroinmunología del Hospital Clinic para conmemorar el día Mundial de la EM

[IDIBAPS @idibaps]

@neuroimmuclinic ➡️Imatge avançada en malalties neuroimmunològiques (ImaginEM)⬅️
@SaraLlufriu

👉https://t.co/Xllo1Ma4gI

[Gary Álvarez.•. @garinho29]

Revisaremos las ventajas de la investigación básica aplicada a la práctica clínica de la #EsclerosisMúltiple, #NMOSD y #MOGAD 🧠 ⚡️